Skip to content

Clinical study of optimal interval time of programmed intermittent epidural bolus when combined with DPE for labor analgesia

Clinical study of optimal interval time of programmed intermittent epidural bolus when combined with DPE for labor analgesia

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047291
Enrollment
Unknown
Registered
2021-06-11
Start date
2021-06-14
Completion date
Unknown
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor pain

Interventions

Experimental group1:35min interval time
Experimental group2:40min interval time
Experimental group3:45min interval time
Experimental group4:50min interval time
Experimental group5:55min interval time

Sponsors

Women and Children's Hospital Affiliated to Jiaxing University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1.Healthy singleton pregnancies; 2.Gestational age >= 37 weeks; 3.American Society of Anesthesiologists Physical Status ii; 4.Spontaneous onset of labor; 5.Latent phase of labor with cervical dilation of 2 - 5 cm; 6.Painful contractions requiring labor epidural analgesia.

Exclusion criteria

Exclusion criteria: 1.Preeclampsia or hypertension; 2.Preexisting or gestational diabetes; 3.BMI > 35 kg/m^2; 4.Any contraindication to regional anesthesia; 5.Allergy or hypersensitivity to ropivacaine or sufentanil; 6.If they had received opioids or sedatives within 4 hours preceding epidural insertion; 7.Labor duration < 60min.

Design outcomes

Primary

MeasureTime frame
Effective analgesic;

Secondary

MeasureTime frame
Characterize of epidural block;Neonatal outcomes;

Countries

China

Contacts

Public ContactXiao Fei

Women and Children's Hospital Affiliated to Jiaxing University

13706597501@163.com+86 13706597501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026